MarketPulse

antimicrobial resistance

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bioversys Ag

BioVersys to Showcase Late-Stage Antibiotic Pipeline at ESCMID 2026

BioVersys will present Phase 3 data for BV100 and collaborate data for BV500 at ESCMID 2026, advancing its antibiotic-resistant infection pipeline.
SGIOYPhase 3 clinical trialantimicrobial resistance
GlobeNewswire Inc.GlobeNewswire Inc.··Bioversys Ag

BioVersys Bolsters NTM Pipeline via Hackensack Meridian Ansamycin Partnership

BioVersys expands NTM pipeline through exclusive ansamycin chemistry partnership with Hackensack Meridian Health, strengthening BV500 program with Shionogi.
SGIOYclinical-stage biopharmaceuticalantimicrobial resistance
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

Pharma QC Testing Market to Reach $17.65B by 2035 on AI, Automation Surge

Global pharmaceutical microbiology QC testing market projected to grow from $5.08B in 2025 to $17.65B by 2035, driven by automation and AI adoption.
TMODHRCRLMKKGYBDX+2regulatory compliancemarket forecast
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Global Antibiotics Market Poised for Steady Growth as Innovation Tackles Resistance Crisis

Global antibiotics market to grow from USD 55.60B in 2025 to USD 70.64B by 2031 at 4.07% CAGR, driven by antimicrobial resistance and innovation.
JNJMRKPFELLYSNY+4Asia Pacific growthpharmaceutical innovation